She researches and writes on topics related to emerging biotechnologies, biobanking, artificial intelligence, and e-health. She has spoken on these topics in conferences and panels around the world. In 2015-16, she consulted for the World Health Organization on the development of the Ebola and Zika vaccines. In 2017, she was named a Bio IP Scholar by the American Society of Law, Medicine & Ethics, and in 2018 she was named a Health Law Scholar by the same institution.